Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
26.20
+0.24 (0.92%)
At close: Aug 1, 2025, 4:00 PM
26.20
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2024.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,897,833
Market Cap
246.05M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TVRD News
- 17 days ago - Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - Business Wire
- 7 weeks ago - Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside - Benzinga
- 2 months ago - Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis - Business Wire
- 2 months ago - Tvardi Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update - Business Wire
- 3 months ago - Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference - Business Wire
- 3 months ago - Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics - GlobeNewsWire